OSI SYSTEMS INC Q1 FY2027 earnings call

• Financial Results: Achieved record Q1 revenues of $403 million (up 5% YoY) and record adjusted EPS of $1.66 (up 17% YoY).
• Backlog Growth: Book-to-bill ratio was 1.4, increasing the backlog to a record $2.1 billion from approximately $1.9 billion at June 30th.
• Security Division Highlights:
  • Won two five-year IDIQ contracts with U.S. Customs and Border Protection totaling ~$285 million in ceiling value; initial delivery orders of ~$21 million received.
  • Executing on the Homeland Defense Over-the-Horizon radar contract (~$235 million not-to-exceed value).
  • Announced additional bookings of ~$90 million in the RF business line.
  • Preparing for the LA28 Olympic Games as an official security technology provider.
  • Expecting strong double-digit growth in service revenues as installed bases roll off warranty.
• Opto Electronics Highlights:
  • Robust bookings across EMS, select circuit, and optoelectronics product lines.
  • Benefiting from global manufacturing footprint diversification trends in aerospace, defense, healthcare, and industrial markets.
• Healthcare Challenges:
  • Facing headwinds from cautious hospital capital spending.
  • Focused on supporting the install base and developing next-generation monitoring platforms.
  • Management expects healthcare to return to growth in upcoming quarters.
• Capital Allocation: Repurchased ~306,000 shares for ~$62 million; Board increased authorization by 1 million shares. Diluted shares reduced by 7% YoY.

• Security: Revenue was $264 million, up 4% year-over-year. This segment holds the largest share of total revenue and maintains a record backlog driven by strong U.S. government contracts (CBP and RF/Homeland Defense). Non-GAAP operating margin was 12.6%.
• Opto Electronics and Manufacturing: Revenue was $120 million (including intercompany sales), up 9% year-over-year, with third-party sales up 16%. This division reported its first-quarter record revenue and highest quarter-end backlog. Non-GAAP operating margin was 12.1%.
• Healthcare: Revenue declined 14% year-over-year due to lower patient monitoring sales as hospitals manage capital spending carefully. This division carries the highest gross margin historically but posted a non-GAAP operating loss of -1.8% in Q1.

• Revenue Guidance: Reaffirmed fiscal 2027 revenue guidance of $1.875 billion to $1.930 billion.
• EPS Guidance: Raised non-GAAP EPS guidance to $11.28–$11.64, representing 9%–12.5% year-over-year growth. The increase is primarily attributed to favorable impacts from stock repurchases made in Q1.
• Quarterly Outlook: Expects Q2 revenues to be modestly down year-over-year due to difficult Middle East comparisons and Mexico program transition impacts.
• H2 Expectations: Anticipates stronger revenue growth in the second half of fiscal 2027, driven by backlog conversion timing, new opportunities, and accelerating security service revenue growth.
• Cash Flow: Continues to expect free cash flow to exceed net income for the full fiscal year.

• Geopolitical Instability: Ongoing conflicts in the Middle East continue to affect activity and order timing in the region, though management views long-term conflict as potentially driving increased security requirements.
• Healthcare Sector Weakness: Hospitals are managing capital spending carefully, leading to significant declines in patient monitoring sales.
• Margin Volatility: Gross margins fluctuate based on product/service mix, volume, supply chain costs, foreign exchange, and tariffs. The current quarter saw margin compression due to a shift toward lower-margin Opto sales and higher-margin Healthcare declines.
• Government Funding Dependency: Reliance on U.S. government procurement timing and potential legislative changes (e.g., reconciliation bills) for programs like Golden Dome and CBP contracts.
• Supply Chain and Execution Risks: Potential disruptions in supply chains and risks associated with converting large backlogs into recognized revenue.

Q: Analyst Josh Nichols asked about the composition of the record backlog and whether any Middle East orders previously pushed out have shipped or will ship soon.

A: Alan Edrick confirmed that while ~$50 million was pushed out from Q4 last year, only ~$8 million shipped in Q1. He stated the balance is expected to materialize mostly in the second half of fiscal 2027 and potentially into fiscal 2028. Ajay Mehra added that despite Middle East challenges, bookings are strong globally, and future conflicts may ultimately drive increased security spending for infrastructure.

Q: Analyst Jason Gursky sought details on service revenue growth expectations and how they impact margins, noting a recent blip.

A: Alan Edrick explained that while Q1 service growth was modest (~5%), significant double-digit acceleration is expected starting in Q2 and strengthening through H2. This growth is driven by products rolling off warranty, aviation services, SAS (SIRSCAN), and RF business expansion. This shift to higher-margin service revenue is expected to expand overall margins throughout the year.

Q: Analyst Christopher Glenn asked about the competitive landscape and differentiation in the RF business, specifically regarding unique offerings and dependence on CERB programs.

A: Ajay Mehra noted that while specific details are restricted due to classified nature, OSI’s offerings are highly regarded and unique, dominating certain market areas. He expressed confidence in the prospects given high customer engagement. Alan Edrick added that revenue recognition on the $235M contract is already underway, providing visibility for fiscal 2027 and beyond.

Q: Analyst Larry Solow asked if the US funding risk, particularly regarding the 'Reconciliation 3.0' bill and Golden Dome, poses a threat to near-term orders.

A: Ajay Mehra stated that much of the funding for DHS and Golden Dome programs was already secured in previous legislation, so near-term operations are safe. However, he noted that while programs have started, there is still a long way to go before new orders are released under the reconciliation bill. He emphasized that while future funding is always watched, current visibility is good.

Q: Analyst Seth Seifman asked about capital deployment priorities, specifically regarding M&A versus organic growth and share buybacks given the strong cash position.

A: Ajay Mehra reiterated that organic growth is the number one priority. While the company remains open to strategic acquisitions that enhance market penetration or provide complementary capabilities, there is no immediate need for acquisition. The company continues to prioritize opportunistic share repurchases alongside executing on the growing backlog.